Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

In a Different Vein: News From the Blood Journals Portfolio

Recent research from ASH’s Blood journals

For articles on research from Blood and Blood Advances published prior to May 2024, visit Written in Blood and Blood Advances in a Different Vein.

Phase III POLARIX Study Compares Symptoms in Patients With DLBCL Treated With Pola-R-CHP or R-CHOP Free
Tess Stafford
October 30, 2025
Immunoglobulin Replacement Therapy Not Associated With Reduced Risk of Infection-Related Hospitalizations Among Patients with CLL Free
Anna Azvolinsky, PhD
October 24, 2025
New Assay Better Identifies MCAS, Study Finds Free
Thomas R. Collins
October 24, 2025
Phase I R/R MM Study of Talquetamab Plus Daratumumab Achieves Safety Endpoint, Durable Responses Free
Katie Robinson
October 24, 2025
FLAG-IDA Plus Venetoclax Performs Well in Children, AYA with Newly Diagnosed AML Free
Leah Lawrence
October 24, 2025
Real-World Study Highlights Disparities in HMA Uptake in MDS Free
Ruth Jessen Hickman, MD
October 24, 2025
Talquetamab Bridging Therapy Enables Transition to BCMA CAR-T for Patients With High-Risk Myeloma Free
Anna Azvolinsky, PhD
September 19, 2025
Quadruplet Induction Therapy for MM Achieves High Rate of MRD Negativity in MIDAS Trial Free
Anna Azvolinsky, PhD
September 19, 2025
ASAP Trial Challenges Standard Practice of Remission Induction Before Transplant in AML Free
Khylia Marshall
September 17, 2025
Marstacimab Provides New Prophylactic Option for Hemophilia A, B Free
Ruth Jessen Hickman, MD
August 29, 2025
Study Identifies CD38 Mutations That Confer Resistance to CD38-Targeting Antibodies in Patients with Multiple Myeloma Free
Anna Azvolinsky, PhD
August 29, 2025
Single-Run NGS Approach for MDS Improves Diagnostic Accuracy, Workflow in Resource-Constrained Setting Free
Katie Robinson
August 21, 2025
Frontline Mogamulizumab Added to CHOP Improves PFS in Older Patients with Aggressive ATL Free
Khylia Marshall
July 31, 2025
Absolute Level of FLC in Patients With AL Amyloidosis Treated with Daratumumab- Based Regimens Not Prognostic Free
Anna Azvolinsky, PhD
July 31, 2025
Immunoglobulin Replacement Therapy in MM May Reduce Risk, Severity of Infections, Development of Hypogammaglobulinemia Free
Katie Robinson
July 31, 2025
Menin Inhibitor Revumenib Yields Clinically Meaningful Responses in R/R NPM1-Mutated AML Free
Leah Lawrence
July 31, 2025
Use of Machine Learning Improves Outcome Predictions for Myelofibrosis After AlloHCT Free
Lara C. Pullen, PhD
June 18, 2025
Circulating Tumor DNA Analysis Identifies Classical Hodgkin Lymphoma Genotypes Free
Katie Robinson
June 16, 2025
Daratumumab Shows Clinical Activity, No New Safety Concerns With Extended Use in Intermediate/High-Risk Smoldering MM Free
Katie Robinson
June 16, 2025
Systematic Review Identifies Sensitive Rapid Point-of-Care ADAMTS13 Assay to Reliably Diagnose TTP Free
Anna Azvolinsky, PhD
June 16, 2025

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
October 2025

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals